000 | 01231 a2200373 4500 | ||
---|---|---|---|
005 | 20250513113015.0 | ||
264 | 0 | _c19970402 | |
008 | 199704s 0 0 eng d | ||
022 | _a0006-4971 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKaufmann, S H | |
245 | 0 | 0 |
_aAltered formation of topotecan-stabilized topoisomerase I-DNA adducts in human leukemia cells. _h[electronic resource] |
260 |
_bBlood _cMar 1997 |
||
300 |
_a2098-104 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aCamptothecin _xanalogs & derivatives |
650 | 0 | 4 |
_aDNA Adducts _xdrug effects |
650 | 0 | 4 |
_aDNA Topoisomerases, Type I _xdrug effects |
650 | 0 | 4 |
_aDNA, Neoplasm _xdrug effects |
650 | 0 | 4 | _aDrug Resistance, Neoplasm |
650 | 0 | 4 | _aElectrophoresis, Polyacrylamide Gel |
650 | 0 | 4 | _aEnzyme Stability |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukemia _xdrug therapy |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aTopotecan |
700 | 1 | _aSvingen, P A | |
700 | 1 | _aGore, S D | |
700 | 1 | _aArmstrong, D K | |
700 | 1 | _aCheng, Y C | |
700 | 1 | _aRowinsky, E K | |
773 | 0 |
_tBlood _gvol. 89 _gno. 6 _gp. 2098-104 |
|
999 |
_c9046764 _d9046764 |